<DOC>
	<DOCNO>NCT00053430</DOCNO>
	<brief_summary>Despite treatment anti-HIV drug , people infect HIV continue problem immune system . This study evaluate whether drug thalidomide , stimulate immune system 's T cell , improve immune system function people HIV .</brief_summary>
	<brief_title>Using Drug Thalidomide Stimulate T Cells HIV-Infected People</brief_title>
	<detailed_description>In patient chronic HIV infection , HIV replication abnormality immune function persist follow treatment highly active antiretroviral therapy ( HAART ) . Specifically , costimulatory T cell interaction impair . The immune modulatory drug thalidomide recently find costimulate T cell . Pharmacologic T cell costimulation may compensate T cell deficiency people HIV disease improve immune function . This study test whether thalidomide treatment enhances HIV cytomegalovirus ( CMV ) -specific immunity patient HIV CMV , evaluate effect thalidomide HIV replication . In study , 40 HIV CMV infect patient HAART 40 HIV uninfected CMV seropositive control randomly assign low dose thalidomide placebo treatment 28 day . T cell response HIV replication genetic diversification assess .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Inclusion Criteria HIVinfected least 5 year prior study entry CD4 count 300/mm3 PreHAART nadir CD4 count 300/mm3 less CMV infection HAART 12 month prior study entry Same effective HAART regimen 3 month prior study entry HIV viral load le 200 copies/ml Clinically stable Exclusion Criteria Active opportunistic infection Females childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Immune Modulation</keyword>
	<keyword>Thalidomide</keyword>
	<keyword>Immune reconstitution</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>